Clinical Trial Update: Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of JTE-451 in moderate to severe plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• JTE-451

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Plaque Psoriasis, Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2021-08-16